This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1533317507312558v1 23/2/167    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Moretti, R. Articles by Pizzolato, G. Search for Related Content PubMed PubMed Citation Articles by Moretti, R. Articles by Pizzolato, G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

Different Responses to Rivastigmine in Subcortical Vascular Dementia and Multi-Infarct Dementia

^* To whom correspondence should be addressed. E-mail: moretti{at}univ.trieste.it.

	Abstract

Vascular dementia (VaD) is associated with a large amount of heterogeneity, as it groups together a broad category of patients in whom various manifestations of cognitive decline are attributed to cerebrovascular or cardiovascular disease. Thus, a study was designed to determine the effects of rivastigmine on cognitive function, global daily living performance, and behavioral disorders in VaD patients versus an active control (nimodipine), stratifying patients according to the type of VaD, subcortical vascular dementia (sVAD), and multi-infarct dementia (MID). The trial was a prospective study. This study shows that long-term treatment with rivastigmine, at dosages approved for therapeutic use in Alzheimer’s disease, produces significant improvement in all behavioral symptoms in 2 forms of VaD, MID and sVaD, except delusions. It also suggests that rivastigmine may enable a reduction in concomitant neuroleptics and benzodiazepines in VaD, especially in MID. The results are discussed with an overview of the literature.

First published on January 9, 2008, doi:10.1177/1533317507312558

American Journal of Alzheimer's Disease and Other Dementias® 2008;23:167.

A more recent version of this article appeared on May 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. S. J. Elliott, C. G. Ballard, R. N. Kalaria, R. Perry, T. Hortobagyi, and P. T. Francis Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition Brain, July 1, 2009; 132(7): 1858 - 1865. [Abstract] [Full Text] [PDF]

				G. E. Lancioni, N. N. Singh, M. F. O'Reilly, J. Sigafoos, M. T. Pangrazio, M. Megna, N. Zonno, M. L. La Martire, K. Pinto,, and M. G. Minervini Persons With Moderate Alzheimer's Disease Improve Activities and Mood via Instruction Technology American Journal of Alzheimer's Disease and Other Dementias, June 1, 2009; 24(3): 246 - 257. [Abstract] [PDF]

				G. E. Lancioni, M. L. La Martire, N. N. Singh, M. F. O'Reilly, J. Sigafoos, K. Pinto, and M. G. Minervini Persons With Mild or Moderate Alzheimer's Disease Managing Daily Activities via Verbal Instruction Technology American Journal of Alzheimer's Disease and Other Dementias, January 1, 2009; 23(6): 552 - 562. [Abstract] [PDF]